Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
about
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisPersistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposurePneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 ImmunityC-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.IL-17A and serum amyloid A are elevated in a cigarette smoke cessation model associated with the persistence of pigmented macrophages, neutrophils and activated NK cellsTargeting pro-resolution pathways to combat chronic inflammation in COPDA novel nonhuman primate model of cigarette smoke-induced airway diseaseNatural and disease-specific autoantibodies in chronic obstructive pulmonary diseaseAirway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in Mice.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Inflammation and immune response in COPD: where do we stand?Induction of pulmonary antibodies against oxidized lipids in mice exposed to cigarette smoke.Recent advances in pre-clinical mouse models of COPD.Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice.Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.B cells in chronic obstructive pulmonary disease: moving to center stage.Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies.Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid AggregatesInfiltration of M2-polarized macrophages in infected lymphatic malformations: possible role in disease progression.Pneumococcal Infection Aggravates Elastase-Induced Emphysema via Matrix Metalloproteinase 12 Overexpression.Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation.A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.Are lymphoid follicles important in the pathogenesis of chronic obstructive pulmonary disease?Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.Update in chronic obstructive pulmonary disease 2013.Vagal innervation is required for the formation of tertiary lymphoid tissue in colitis.Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD.Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease.Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease.Animal models of chronic obstructive pulmonary diseaseRole of inflammatory cells in airway remodeling in COPDT Cells That Help B Cells in Chronically Inflamed TissuesTertiary Lymphoid Structures: Autoimmunity Goes Local
P2860
Q27316615-6DEA66D0-B668-4E45-BFFA-60DBCCAA1A96Q28660263-8F377074-C891-4B11-8FFA-DED83D1DC673Q33620933-7F06D5C4-E99B-42F7-8F67-089D4A169B79Q33901646-310A85F5-5719-409C-8AF5-9BAE196A4A2AQ34535911-01E28725-48AF-4E4E-A276-339A12B0638DQ34628609-D75634D7-3966-48E4-B565-4F77F6733066Q35143749-CE27DF2B-3500-4468-8282-A08335B8B190Q35198950-9B5A0CE1-4C8C-4744-B393-73CE75E01C14Q35661242-724AD7CF-4C71-433B-B988-92B0A961CAEEQ36546997-A4DAD9CE-2C89-4523-94B9-6EDCE29FEB1CQ37057836-74F6DD0F-8947-4DFB-A3EE-EB7551696321Q37150877-55101361-8D4D-47FC-8356-B42E11B493D3Q37426720-9BA17FEA-4CEE-4B10-A239-D42ADCC46041Q37556221-E5D69ED9-CA95-4DC1-B9E1-BEF59286F9EFQ38452733-82A22258-60E8-4395-9DA4-40CA87D24257Q38903995-FF2C0995-414F-4ACF-8E63-4B007E333350Q38932311-6A849B15-AD46-4DA6-B988-F71DF5B6D6F6Q40249394-6E6DBEF1-AE61-40F3-AF37-2005435412A7Q40332169-119F352A-F123-4FD9-A205-8F620D668CF8Q40792912-23668669-2FA1-4B31-9AAF-5B26BD5CD11BQ40911935-1A7A3D0B-4DD1-48F6-9C4E-EB22FFD9B601Q41157946-C314B696-7055-4AF1-851C-F69306655B40Q46225129-A3654E22-B968-451D-830D-649841CF55DBQ47885104-B88FFD8D-E314-4F86-9CAA-5566433D11FAQ48058728-A6A79358-431D-46CE-94BE-E819AEB23145Q49120393-3F55B94C-8259-446E-8168-5C4F91826254Q51082449-554D65CE-02AE-4D10-BBC5-DF7E779340AFQ51617066-1734BD97-B51B-4954-9B7A-A912939EBCF9Q51703615-5D8A1A2F-D139-41A5-91FC-73D5CDF9C7C7Q52576641-CCA6470B-0774-4744-8A65-C3C32D9A4272Q52720696-506EC34A-E085-40A1-9F33-0389A2E89713Q55440438-FA456968-CC3E-449D-B1B6-255279C18946Q57097245-5C9BB5D4-3566-46AE-AE9F-EAC55EB589F9Q57815421-4CCBD0B9-3929-4902-B425-47EC95EA7A7CQ58712847-69E04967-3D7B-46A9-8D2E-6AD5F69CF59EQ58746430-C3FC27AE-5331-441E-886D-76D1A7AB7100
P2860
Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@en
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@nl
type
label
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@en
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@nl
prefLabel
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@en
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Role of CXCL13 in cigarette sm ...... obstructive pulmonary disease.
@en
P2093
Bart N Lambrecht
Claudie Bantsimba-Malanda
Danen Mootoosamy Cunoosamy
Fien M Verhamme
Guy F Joos
Guy G Brusselle
Leen J M Seys
Ronald Herbst
P2860
P304
P356
10.1164/RCCM.201211-2055OC
P407
P577
2013-08-01T00:00:00Z